TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
BLTE

Belite Bio Inc

Healthcare · Biotechnology

167.30$ -1.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement BLTE
Line item 2020 2021 2022 2023 2024 2025
– – – – – –
– +76.5% +560.0% +101.5% +12.5% –
– – – – – –
– +101.2% +19.5% +180.1% +20.5% +51.6%
– +15.7% +66.2% +72.7% +47.4% +286.1%
– +70.6% +30.9% +147.0% +26.3% +110.5%
– – – – – –
– -76.2% +220.0% +56.3% -20.0% -90.0%
– – – – – –
– +12,500.0% -237.3% – -33.3% –
– – – – – –
– – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?